EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Legacy 4(1 H )-Quinolone Scaffolds Activity against Acute and Chronic Toxoplasma gondii Infection

Melissa A Sleda, Khaly Diagne, Victoria Mills Clifton, Baihetiya Baierna, Roman Manetsch, Silvia N J Moreno iD

ACS Infectious Diseases · 12.06.2026 · 12 (6) · 1901-1914

DOI: 10.1021/acsinfecdis.5c01074 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 26.05.2026. Verfasst von Melissa A Sleda und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia 30602, United States. Hauptthemen laut MEDLINE: Toxoplasma, Quinolones, Toxoplasmosis, Antiprotozoal Agents. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ToxoplasmaQuinolonesToxoplasmosisAntiprotozoal AgentsAnimalsMiceFemaleChronic DiseaseMitochondriaHumansToxoplasmosis, Animal

Stichwörter der Autor:innen

Toxoplasma gondiibradyzoiteschronic infectionelectron transport chainquinolonestissue cysts

Substanzen

Quinolones6-Chloro-7-methoxy-2-methyl-3-(4-(4-(trifluoromethoxy)phenoxy)phenyl)quinolin-4(1H)-oneAntiprotozoal Agents

Autor:innen und Institutionen

  • Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia 30602, United States.
  • Department of Chemistry and Chemical Biology, Northeastern University, Boston, Massachusetts 02115, United States.
  • Department of Cellular Biology, University of Georgia, Athens, Georgia 30602, United States.
  • Department of Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts 02115, United States.
  • Center for Drug Discovery, Northeastern University, Boston, Massachusetts 02115, United States.
  • Barnett Institute of Chemical and Biological Analysis, Northeastern University, Boston, Massachusetts 02115, United States.

ORCID-Profile: Silvia N J Moreno

Förderung

  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Sleda, M. A., Diagne, K., Clifton, V. M., Baierna, B., Manetsch, R., & Moreno, S. N. J. (2026). Legacy 4(1 H )-Quinolone Scaffolds Activity against Acute and Chronic Toxoplasma gondii Infection. ACS Infectious Diseases, 12(6), 1901-1914. https://doi.org/10.1021/acsinfecdis.5c01074

Vancouver

Sleda MA, Diagne K, Clifton VM, Baierna B, Manetsch R, Moreno SNJ. Legacy 4(1 H )-Quinolone Scaffolds Activity against Acute and Chronic Toxoplasma gondii Infection. ACS Infectious Diseases. 2026;12(6):1901-1914. doi:10.1021/acsinfecdis.5c01074

BibTeX
@article{Sleda2026,
  author = {Sleda, Melissa A and Diagne, Khaly and Clifton, Victoria Mills and Baierna, Baihetiya and Manetsch, Roman and Moreno, Silvia N J},
  title = {Legacy 4(1 H )-Quinolone Scaffolds Activity against Acute and Chronic Toxoplasma gondii Infection},
  journal = {ACS Infectious Diseases},
  year = {2026},
  volume = {12},
  number = {6},
  pages = {1901--1914},
  doi = {10.1021/acsinfecdis.5c01074}
}
Kostenlos starten →